Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FP.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DA.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.68 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.16.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DN.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.28NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.5.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DN.1.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.84 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.99NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBF.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.343NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19749.2South Korea
AY.4.17 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.25.1.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.409NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.83NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.310NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.362.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.162NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Y.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.86NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.154NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.4.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
A.2.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.41NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.137NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.446NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.76 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.398NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.163NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.3 (Theta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.38.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAVNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.1.4.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BM.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.77NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CP.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FC.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BY.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.123 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.71NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21359South Korea
BA.2.12.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DN.1.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.51NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used